Literature DB >> 23827649

Osteoprotegerin: multiple partners for multiple functions.

Marc Baud'huin1, Laurence Duplomb, Stéphane Teletchea, François Lamoureux, Carmen Ruiz-Velasco, Mike Maillasson, Françoise Redini, Marie-Françoise Heymann, Dominique Heymann.   

Abstract

Osteoprotegerin (OPG) is an essential secreted protein in bone turnover due to its role as a decoy receptor for the Receptor Activator of Nuclear Factor-kB ligand (RANKL) in the osteoclasts, thus inhibiting their differentiation. However, there are additional ligands of OPG that confer various biological functions. OPG can promote cell survival, cell proliferation and facilitates migration by binding TNF-related apoptosis inducing ligand (TRAIL), glycosaminoglycans or proteoglycans. A large number of in vitro, pre-clinical and clinical studies provide evidences of OPG involvement in vascular, bone, immune and tumor biology. This review describes an overview of the different OPG ligands regulating its biological functions.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cell adhesion; Glycosaminoglycans; Monocytes; Osteoprotegerin

Mesh:

Substances:

Year:  2013        PMID: 23827649     DOI: 10.1016/j.cytogfr.2013.06.001

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  50 in total

1.  Osteoprotegerin exposure at different stages of osteoclastogenesis differentially affects osteoclast formation and function.

Authors:  Hongyan Zhao; Jianhong Gu; Nannan Dai; Qian Gao; Dong Wang; Ruilong Song; Wei Liu; Yan Yuan; Jianchun Bian; Xuezhong Liu; Zongping Liu
Journal:  Cytotechnology       Date:  2015-06-05       Impact factor: 2.058

2.  Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.

Authors:  J H Kang; H M Ko; J S Moon; H I Yoo; J Y Jung; M S Kim; J T Koh; W J Kim; S H Kim
Journal:  J Dent Res       Date:  2014-09-25       Impact factor: 6.116

Review 3.  Harnessing the versatile role of OPG in bone oncology: counterbalancing RANKL and TRAIL signaling and beyond.

Authors:  Maria V Deligiorgi; Mihalis I Panayiotidis; John Griniatsos; Dimitrios T Trafalis
Journal:  Clin Exp Metastasis       Date:  2019-10-01       Impact factor: 5.150

4.  Elevated serum osteoprotegerin is associated with increased left ventricular mass index and myocardial stiffness.

Authors:  Daisuke Kamimura; Takeki Suzuki; Anna L Furniss; Michael E Griswold; Iftikhar J Kullo; Merry L Lindsey; Michael D Winniford; Kenneth R Butler; Thomas H Mosley; Michael E Hall
Journal:  J Cardiovasc Med (Hagerstown)       Date:  2017-12       Impact factor: 2.160

5.  Osteoprotegerin deficiency leads to deformation of the articular cartilage in femoral head.

Authors:  Yi Liu; Jianping Ge; Danying Chen; Yuteng Weng; Haiming Du; Yao Sun; Qi Zhang
Journal:  J Mol Histol       Date:  2016-08-19       Impact factor: 2.611

6.  Osteoblastic heparan sulfate regulates osteoprotegerin function and bone mass.

Authors:  Satoshi Nozawa; Toshihiro Inubushi; Fumitoshi Irie; Iori Takigami; Kazu Matsumoto; Katsuji Shimizu; Haruhiko Akiyama; Yu Yamaguchi
Journal:  JCI Insight       Date:  2018-02-08

Review 7.  Therapeutic applications of TRAIL receptor agonists in cancer and beyond.

Authors:  Gustavo P Amarante-Mendes; Thomas S Griffith
Journal:  Pharmacol Ther       Date:  2015-09-05       Impact factor: 12.310

Review 8.  Targeting the Muscle-Bone Unit: Filling Two Needs with One Deed in the Treatment of Duchenne Muscular Dystrophy.

Authors:  Antoine Boulanger Piette; Dounia Hamoudi; Laetitia Marcadet; Françoise Morin; Anteneh Argaw; Leanne Ward; Jérôme Frenette
Journal:  Curr Osteoporos Rep       Date:  2018-10       Impact factor: 5.096

9.  Cystathionine gamma lyase aggravates orthodontic root resorption in mice.

Authors:  Caizhu Lu; Liyuan Chen; Yongmei Hua
Journal:  Ann Transl Med       Date:  2019-12

10.  Proteomic analysis reveals dexamethasone rescues matrix breakdown but not anabolic dysregulation in a cartilage injury model.

Authors:  Rebecca Mae Black; Yang Wang; André Struglics; Pilar Lorenzo; Viveka Tillgren; Martin Rydén; Alan J Grodzinsky; Patrik Önnerfjord
Journal:  Osteoarthr Cartil Open       Date:  2020-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.